Survival in malignant astrocytoma at King Khalid University Hospital
Annals of Saudi Medicine. 1995; 15 (3): 231-5
in English
| IMEMR
| ID: emr-36313
ABSTRACT
Malignant astrocytoma [Kernohan grade III and IV] still has one of the worst outcomes of all malignant tumors. To determine factors affecting the survival of patients with malignant astrocytoma in Saudi Arabia, a retrospective study of 76 cases that were treated at King Khalid University Hospital over one decade was carried out. Kaplan-Meier survival diagrams were constructed for each prognostic factor. Twenty-eight percent of cases survived two years. A significantly better survival rate was found in females, patients = 50 years and patients who had re-operation for a recurrence. A better survival rate which did not reach significance was found in patients with grade III tumors, patients with a Karnofsky score of >/= 70 at presentation, patients who had craniotomy and excision and patients who had radiotherapy. It is suggested that to improve the outcome of patients with malignant astrocytoma, aggressive surgical excision with radiotherapy [and possibly chemotherapy] is required
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Survival Analysis
/
Glioblastoma
/
Neoplasms
Language:
English
Journal:
Ann. Saudi Med.
Year:
1995
Similar
MEDLINE
...
LILACS
LIS